| Quarterly Financials | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 270 | 285 | 278 | 275 | 276 | 691 | 835 | 831 | 1,026 | 1,050 | 1,023 | 964 | 1,098 | 1,163 | 1,186 | 1,255 | 1,326 | 1,409 | 1,381 | 1,468 | 1,578 | 1,748 | 1,902 |
| Expenses | 239 | 253 | 245 | 228 | 514 | 564 | 636 | 634 | 756 | 787 | 729 | 729 | 802 | 818 | 828 | 874 | 948 | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,443 |
| EBITDA | 31 | 31 | 32 | 47 | -239 | 127 | 200 | 197 | 270 | 262 | 293 | 235 | 296 | 345 | 359 | 381 | 379 | 433 | 432 | 427 | 422 | 491 | 459 |
| Operating Profit % | 9 % | 10 % | 8 % | 8 % | -101 % | 13 % | 20 % | 21 % | 24 % | 23 % | 25 % | 22 % | 25 % | 28 % | 28 % | 28 % | 26 % | 28 % | 29 % | 27 % | 25 % | 26 % | 23 % |
| Depreciation | 12 | 11 | 11 | 12 | 26 | 52 | 48 | 48 | 54 | 54 | 55 | 58 | 57 | 58 | 57 | 60 | 56 | 58 | 61 | 70 | 77 | 84 | 98 |
| Interest | 10 | 21 | 27 | 25 | 35 | 53 | 46 | 45 | 27 | 27 | 25 | 22 | 22 | 22 | 20 | 20 | 19 | 9 | 11 | 21 | 24 | 34 | 52 |
| Profit Before Tax | 9 | -0 | -6 | 10 | -300 | 22 | 105 | 105 | 190 | 182 | 213 | 154 | 216 | 265 | 281 | 301 | 304 | 366 | 360 | 336 | 321 | 374 | 309 |
| Tax | -0 | 1 | -4 | -43 | 14 | 6 | 15 | 35 | 43 | 37 | 23 | 31 | 44 | -192 | 59 | 50 | 63 | 90 | 70 | 84 | 85 | 92 | 70 |
| Net Profit | 9 | -1 | -2 | 53 | -314 | 17 | 90 | 70 | 147 | 145 | 190 | 124 | 173 | 457 | 222 | 251 | 240 | 277 | 289 | 252 | 236 | 282 | 239 |
| EPS in ₹ | 0.17 | -0.03 | -0.03 | 0.91 | -4.34 | 0.18 | 1.00 | 0.76 | 1.52 | 1.50 | 1.96 | 1.28 | 1.78 | 4.72 | 2.29 | 2.58 | 2.47 | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 |
Max Healthcare Institute
1,161.05
+14.80
(1.29%)
Market Cap
1,12,869.39 Cr
EPS
10.89
PE Ratio
105.07
Dividend Yield
0.13 %
Industry
Healthcare Services52 Week High
1,227.95
52 Week Low
737.50
PB Ratio
12.67
Debt to Equity
0.13
Sector
Hospitals
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from20 analysts
Company News
View All News
Max Healthcare Institute Ltd. Sees Large Block Trade on NSEToday
A significant block trade of approximately 203,079 shares of Max Healthcare Institute Ltd. occurred on the National Stock Exchange (NSE) at a price of Rs. 1160.00 per share. The total value of the transaction amounted to Rs. 23.56 crores.
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 1,161.05 | 1,12,869.39 | 105.07 | 5,584.10 | 18.77 | 1,058 | -17.46 | 65.37 | |
| 6,649.70 | 95,612.48 | 72.60 | 19,165.50 | 14.74 | 917 | 49.14 | 62.72 | |
| 646.45 | 48,804.27 | 62.50 | 6,931.20 | 8.99 | 645 | 89.49 | 58.60 | |
| 1,257.70 | 33,780.24 | 65.17 | 2,759.20 | 25.09 | 326 | 15.71 | 56.75 | |
| 1,651.25 | 33,745.08 | 43.57 | 5,093.40 | 10.96 | 790 | 2.66 | 68.00 | |
| 644.30 | 25,780.95 | 73.54 | 2,511.20 | 12.94 | 336 | 20.76 | 70.04 | |
| 440.85 | 22,021.03 | 83.02 | 3,723.70 | 22.85 | 205 | -69.22 | 52.98 | |
| 1,341.80 | 13,626.20 | 57.92 | 1,334.00 | 10.76 | 218 | 10.06 | 57.97 | |
| 1,704.80 | 11,177.70 | 56.93 | 1,095.50 | 21.32 | 177 | 20.14 | 72.89 | |
| 530.85 | 7,400.19 | 136.75 | 1,929.10 | 12.97 | 41 | 129.41 | 67.81 |
Growth Rate
Revenue Growth
18.77 %
Net Income Growth
-4.16 %
Cash Flow Change
-12.64 %
ROE
-15.51 %
ROCE
4.66 %
EBITDA Margin (Avg.)
1.91 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,824 | 8,544 | 9,189 | 10,102 | 12,000 |
| Fixed Assets | 740 | 1,478 | 2,244 | 2,227 | 2,192 | 2,380 | 6,536 | 7,018 | 7,039 | 8,784 |
| Current Assets | 383 | 289 | 349 | 454 | 447 | 768 | 1,125 | 1,000 | 1,943 | 1,706 |
| Capital Work in Progress | 18 | 12 | 46 | 38 | 87 | 6 | 27 | 151 | 252 | 553 |
| Investments | 143 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 |
| Other Assets | 552 | 728 | 870 | 1,049 | 1,086 | 1,439 | 1,981 | 2,020 | 2,810 | 2,661 |
| Total Liabilities | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,824 | 8,544 | 9,189 | 10,102 | 12,000 |
| Current Liabilities | 282 | 419 | 381 | 477 | 1,140 | 1,474 | 777 | 757 | 1,046 | 1,249 |
| Non Current Liabilities | 339 | 672 | 1,660 | 1,806 | 1,262 | 1,363 | 2,129 | 2,149 | 1,647 | 2,343 |
| Total Equity | 832 | 1,127 | 1,119 | 1,031 | 963 | 987 | 5,639 | 6,283 | 7,410 | 8,408 |
| Reserve & Surplus | 343 | 587 | 655 | 627 | 426 | 450 | 4,673 | 5,313 | 6,439 | 7,436 |
| Share Capital | 489 | 533 | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 16 | -40 | 4 | -6 | -2 | 267 | 516 | -318 | 893 | -395 |
| Investing Activities | -194 | -364 | -104 | -124 | -17 | -127 | 206 | -764 | -102 | -1,253 |
| Operating Activities | 64 | 53 | 156 | 166 | 89 | 250 | 118 | 741 | 1,284 | 1,122 |
| Financing Activities | 145 | 271 | -48 | -48 | -74 | 144 | 191 | -294 | -289 | -264 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 70.46 % | 70.46 % | 60.91 % | 60.68 % | 50.64 % | 50.64 % | 23.80 % | 23.78 % | 23.77 % | 23.76 % | 23.76 % | 23.75 % | 23.75 % | 23.74 % | 23.74 % | 23.74 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.01 % | 0.01 % | 57.33 % | 56.98 % | 57.29 % | 56.93 % |
| DIIs | 4.86 % | 7.93 % | 8.70 % | 15.60 % | 17.49 % | 19.26 % | 21.00 % | 20.47 % | 19.35 % | 11.90 % | 11.32 % | 11.34 % | 14.96 % | 15.36 % | 15.14 % | 15.55 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 5.18 % | 5.76 % | 5.20 % | 5.23 % | 5.41 % | 4.94 % | 4.54 % | 4.36 % | 3.72 % | 3.54 % | 3.55 % | 3.34 % | 3.29 % | 3.24 % | 3.18 % | 3.13 % |
| Others | 19.50 % | 15.84 % | 25.18 % | 18.49 % | 26.46 % | 25.16 % | 50.65 % | 51.38 % | 53.15 % | 60.80 % | 61.36 % | 61.56 % | 0.67 % | 0.67 % | 0.65 % | 0.64 % |
| No of Share Holders | 45,339 | 70,655 | 91,937 | 1,11,877 | 1,20,079 | 1,05,000 | 1,01,659 | 1,11,701 | 1,04,656 | 1,11,374 | 1,18,635 | 1,11,338 | 1,27,009 | 1,36,254 | 1,37,856 | 1,40,028 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1.5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.13 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Outcome Of Board Meeting
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Approval Of Scheme Of Amalgamation Between ALPS Hospital Limited And Max Hospitals And Allied Services Limited
Approval Of Scheme Of Amalgamation Between ALPS Hospital Limited And Max Hospitals And Allied Services Limited
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Change in Management
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Announcement under Regulation 30 (LODR)-Newspaper Publication
Audio Recording Of Earnings Call Held On January 31 2025
Integrated Filing (Financial)
Agreement To Lease For Setting Up ~500 Bedded Build-To-Suit Hospital At Thane Maharashtra
Presentation On Earnings Update
Announcement under Regulation 30 (LODR)-Acquisition
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Board Meeting Outcome for Meeting Held On January 30 2025
Results- Financial Results For Quarter And Nine Months Ended December 31 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Board Meeting Intimation for Consideration And Approval Of Financial Results
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Change Of Name Of Registrar And Share Transfer Agent
Closure of Trading Window
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Audio Recording Of Earnings Call Held On November 7, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Presentation On Earnings Update
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Board Meeting Outcome for Meeting Held On November 5, 2024
Results - Financial Results For Quarter And Half Year Ended September 30, 2024
Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Board Meeting Intimation for Consideration And Approval Of Financial Results
Update On Voluntary Liquidation Of ET Planners Private Limited, A Step Down Wholly-Owned Subsidiary Of The Company
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Announcement under Regulation 30 (LODR)-Change in Management
Technical Indicators
RSI(14)
Neutral 65.37
ATR(14)
Less Volatile 43.06
STOCH(9,6)
Overbought 87.70
STOCH RSI(14)
Overbought 94.76
MACD(12,26)
Bullish 22.95
ADX(14)
Weak Trend 22.88
UO(9)
Bearish 68.84
ROC(12)
Uptrend And Accelerating 12.17
WillR(14)
Overbought -17.34
About Max Healthcare Institute
Max Healthcare Institute Limited is an Indian integrated healthcare provider operating a network of healthcare facilities, primarily in North India. The company offers a range of medical services including primary, secondary, tertiary, and quaternary care across various specialties. It operates 17 healthcare facilities in Delhi NCR, Haryana, Punjab, Uttarakhand, and Maharashtra. Max Healthcare has two strategic business units: Max Lab, which provides diagnostic services outside its hospital network, and Max@Home, offering health and wellness services at home. The company is listed on the BSE and NSE, with Mr. Abhay Soi and Kayak Investments Holding Pte. Ltd. as its current promoters.
Website
Chairperson NameAbhay Soi
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
